Incorporating Oncology Methods in CNS Drug Development
March 22nd 2017We previously covered the challenges that biopharmaceutical enterprises are facing when it comes to developing CNS medical products at ExL’s 2nd CNS Clinical Trial Forum. In this interview, Glenn Morrison, Executive Director of Clinical Development at Zogenix, will discuss how biopharmaceutical enterprises can apply techniques used in oncology clinical trials in CNS development.